Biocompatibility study of theophylline/chitosan/β-cyclodextrin microspheres as pulmonary delivery carriers
Authors:
- 10 January 2009
- journal article
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 20 (6) , 1321-1330
Abstract
To evaluate the biocompatibility of the theophylline/chitosan/β-cyclodextrin microspheres, which has a potential application in pulmonary delivery system. The detection of LDH and protein in BALF was examined acute cell toxicity, hemolysis test was carried out to estimate blood toxicity; Micronucleus Test was reckoned to identify genotoxicity, MTT assay was used to evaluate in vitro cytotoxicity, and muscle implantation investigated the tissue biocompatibility. The results demonstrated that the total contents of protein and LDH in BALF were not significantly different from that of normal group. The experiments showed that the cytotoxicity was depended on the concentration and had no cytoxicity at low concentration and no hemolysis activity. The micronucleus frequency of MS B was 0.99‰, which showed no genotoxic effects either. The results of implantation showed that the microspheres had no effect on hemoglobin and no toxicity in the liver and kidney. The inflammations of muscle tissue were not significantly different from that of operative suture, therefore, the MS B possess high good biocompatibility and can be applied in pulmonary sustained release systems.Keywords
This publication has 28 references indexed in Scilit:
- Chitosan and chitosan/β‐cyclodextrin microspheres as sustained‐release drug carriersJournal of Applied Polymer Science, 2006
- Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctionsJournal of Controlled Release, 2005
- Chitosan/Cellulose Acetate Microspheres Preparation and Ranitidine Release In VitroPharmaceutical Development and Technology, 2005
- Pulmonary Gene Delivery by Chitosan–pDNA Complex Powder Prepared by a Supercritical Carbon Dioxide ProcessJournal of Pharmaceutical Sciences, 2003
- Formulation factors in preparing BTM–chitosan microspheres by spray drying methodInternational Journal of Pharmaceutics, 2002
- Mucoadhesive DL-Lactide/Glycolide Copolymer Nanospheres Coated with Chitosan to Improve Oral Delivery of ElcatoninPharmaceutical Development and Technology, 2000
- Investigation of a pMDI system containing chitosan microspheres and P134aInternational Journal of Pharmaceutics, 1998
- Biochemical significance of exogenous chitins and chitosans in animals and patientsCarbohydrate Polymers, 1993
- Chitosan-as a BiomaterialBiomaterials, Artificial Cells and Artificial Organs, 1990
- Early damage indicators in the lung I. Lactate dehydrogenase activity in the airwaysToxicology and Applied Pharmacology, 1978